Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
GADOFOSVESET
(2008)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
GADOFOSVESET
×
Maximum Phase:
4
First Approval:
2008
UNII:
E65RW73PHS
Molecule Type:
Small molecule
Molecular Formula:
C33H44GdN3O14P+3
Molecular Weight:
894.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TAPENTADOL HYDROCHLORIDE
(2008)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Acute Pain; Chronic Pain; Neuralgia; Pain
TAPENTADOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
71204KII53
Molecule Type:
Small molecule
Molecular Formula:
C14H24ClNO
Molecular Weight:
257.81
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FOSPROPOFOL
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSPROPOFOL
×
Maximum Phase:
4
First Approval:
2008
UNII:
LZ257RZP7K
Molecule Type:
Small molecule
Molecular Formula:
C13H21O5P
Molecular Weight:
288.28
AlogP:
3.38
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ELTROMBOPAG
(2008)
Small molecule
Unknown
ORAL
Approved
Hemorrhage
ELTROMBOPAG
×
Maximum Phase:
4
First Approval:
2008
UNII:
S56D65XJ9G
Molecule Type:
Small molecule
Molecular Formula:
C25H22N4O4
Molecular Weight:
442.48
AlogP:
4.56
PSA:
114.59
HBD:
3.0
HBA:
#RotB:
5.0
Source:
FOSAPREPITANT
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSAPREPITANT
×
Maximum Phase:
4
First Approval:
2008
UNII:
6L8OF9XRDC
Molecule Type:
Small molecule
Molecular Formula:
C23H22F7N4O6P
Molecular Weight:
614.41
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DESVENLAFAXINE
(2008)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major
DESVENLAFAXINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
NG99554ANW
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO2
Molecular Weight:
263.38
AlogP:
2.73
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RUFINAMIDE
(2008)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Lennox Gastaut Syndrome; Seizures
RUFINAMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
WFW942PR79
Molecule Type:
Small molecule
Molecular Formula:
C10H8F2N4O
Molecular Weight:
238.2
AlogP:
0.7
PSA:
73.8
HBD:
1.0
HBA:
#RotB:
3.0
Source:
METHYLNALTREXONE BROMIDE
(2008)
Small molecule
Mu opioid receptor antagonist
ORAL; SUBCUTANEOUS
Approved
Constipation
METHYLNALTREXONE BROMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
RFO6IL3D3M
Molecule Type:
Small molecule
Molecular Formula:
C21H26BrNO4
Molecular Weight:
436.35
AlogP:
1.67
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BENDAMUSTINE HYDROCHLORIDE
(2008)
Small molecule
DNA inhibitor
INJECTION; IV (INFUSION)
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin
BENDAMUSTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
981Y8SX18M
Molecule Type:
Small molecule
Molecular Formula:
C16H22Cl3N3O2
Molecular Weight:
394.73
AlogP:
3.26
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LEVOLEUCOVORIN CALCIUM
(2008)
Small molecule
Unknown
INTRAVENOUS
Approved
Colorectal Neoplasms; Osteosarcoma
LEVOLEUCOVORIN CALCIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
778XL6VBS8
Molecule Type:
Small molecule
Molecular Formula:
C20H21CaN7O7
Molecular Weight:
511.51
AlogP:
-0.73
PSA:
219.84
HBD:
7.0
HBA:
#RotB:
10.0
Source:
FESOTERODINE FUMARATE
(2008)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
FESOTERODINE FUMARATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
EOS72165S7
Molecule Type:
Small molecule
Molecular Formula:
C30H41NO7
Molecular Weight:
527.66
AlogP:
5.38
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
10.0
Source:
TAPENTADOL
(2008)
Small molecule
Unknown
ORAL
Approved
Pain
TAPENTADOL
×
Maximum Phase:
4
First Approval:
2008
UNII:
H8A007M585
Molecule Type:
Small molecule
Molecular Formula:
C14H23NO
Molecular Weight:
221.34
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALVIMOPAN
(2008)
Small molecule
Mu opioid receptor antagonist
Unknown
Approved
Constipation
ALVIMOPAN
×
Maximum Phase:
4
First Approval:
2008
UNII:
677C126AET
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O4
Molecular Weight:
424.54
AlogP:
3.05
PSA:
89.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ARTEMETHER
(2009)
Small molecule
Ferriprotoporphyrin IX inhibitor
Unknown
Approved
Malaria
ARTEMETHER
×
Maximum Phase:
4
First Approval:
2009
UNII:
C7D6T3H22J
Molecule Type:
Small molecule
Molecular Formula:
C16H26O5
Molecular Weight:
298.38
AlogP:
2.84
PSA:
46.15
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESLICARBAZEPINE ACETATE
(2009)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
ESLICARBAZEPINE ACETATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
BEA68ZVB2K
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O3
Molecular Weight:
296.33
AlogP:
3.06
PSA:
72.63
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TELAVANCIN
(2009)
Small molecule
Unknown
INJECTION
Approved
Bacterial Infections
TELAVANCIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
XK134822Z0
Molecule Type:
Small molecule
Molecular Formula:
C80H106Cl2N11O27P
Molecular Weight:
1755.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MILNACIPRAN
(2009)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
MILNACIPRAN
×
Maximum Phase:
4
First Approval:
2009
UNII:
G56VK1HF36
Molecule Type:
Small molecule
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OLANZAPINE PAMOATE
(2009)
Small molecule
D2-like dopamine receptor antagonist
INTRAMUSCULAR
Approved
Bipolar Disorder; Mental Disorders; Schizophrenia
OLANZAPINE PAMOATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
X7S6Q4MHCB
Molecule Type:
Small molecule
Molecular Formula:
C40H38N4O7S
Molecular Weight:
718.83
AlogP:
3.44
PSA:
30.87
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SAXAGLIPTIN HYDROCHLORIDE
(2009)
Small molecule
Dipeptidyl peptidase IV inhibitor
ORAL
Approved
Diabetes Mellitus, Type 2
SAXAGLIPTIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
Z8J84YIX6L
Molecule Type:
Small molecule
Molecular Formula:
C18H26ClN3O2
Molecular Weight:
351.88
AlogP:
1.16
PSA:
90.35
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ASENAPINE
(2009)
Small molecule
Unknown
SUBLINGUAL; TRANSDERMAL
Approved
Bipolar Disorder; Psychotic Disorders; Schizophrenia
ASENAPINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
JKZ19V908O
Molecule Type:
Small molecule
Molecular Formula:
C17H16ClNO
Molecular Weight:
285.77
AlogP:
4.26
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ASENAPINE MALEATE
(2009)
Small molecule
Dopamine D2 receptor antagonist
SUBLINGUAL
Approved
Bipolar Disorder; Schizophrenia
ASENAPINE MALEATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
CU9463U2E2
Molecule Type:
Small molecule
Molecular Formula:
C21H20ClNO5
Molecular Weight:
401.85
AlogP:
4.26
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PAZOPANIB HYDROCHLORIDE
(2009)
Small molecule
Fibroblast growth factor receptor 1 inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Sarcoma
PAZOPANIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
33Y9ANM545
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClN7O2S
Molecular Weight:
473.99
AlogP:
3.14
PSA:
119.03
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BEPOTASTINE BESYLATE
(2009)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Conjunctivitis, Allergic; Pruritus
BEPOTASTINE BESYLATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
6W18MO1QR3
Molecule Type:
Small molecule
Molecular Formula:
C27H31ClN2O6S
Molecular Weight:
547.07
AlogP:
4.17
PSA:
62.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CODEINE SULFATE
(2009)
Small molecule
Opioid receptors; mu/kappa/delta agonist
ORAL
Approved
Pain
CODEINE SULFATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
11QV9BS0CB
Molecule Type:
Small molecule
Molecular Formula:
C36H50N2O13S
Molecular Weight:
750.86
AlogP:
1.5
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DEXLANSOPRAZOLE
(2009)
Small molecule
Potassium-transporting ATPase inhibitor
ORAL
Approved
Duodenal Ulcer; Esophagitis; Gastroesophageal Reflux; Heartburn; Peptic Ulcer; Stomach Ulcer
DEXLANSOPRAZOLE
×
Maximum Phase:
4
First Approval:
2009
UNII:
UYE4T5I70X
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3N3O2S
Molecular Weight:
369.37
AlogP:
3.52
PSA:
67.87
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DRONEDARONE
(2009)
Small molecule
Unknown
ORAL
Approved
Arrhythmias, Cardiac
DRONEDARONE
×
Maximum Phase:
4
First Approval:
2009
UNII:
JQZ1L091Y2
Molecule Type:
Small molecule
Molecular Formula:
C31H44N2O5S
Molecular Weight:
556.77
AlogP:
7.05
PSA:
88.85
HBD:
1.0
HBA:
#RotB:
18.0
Source:
ILOPERIDONE
(2009)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Psychotic Disorders; Schizophrenia
ILOPERIDONE
×
Maximum Phase:
4
First Approval:
2009
UNII:
VPO7KJ050N
Molecule Type:
Small molecule
Molecular Formula:
C24H27FN2O4
Molecular Weight:
426.49
AlogP:
4.83
PSA:
64.8
HBD:
0.0
HBA:
#RotB:
8.0
Source:
CAPSAICIN
(2009)
Small molecule
Vanilloid receptor opener
TOPICAL
Approved
Arthralgia; Arthritis; Back Pain; Bursitis; Contusions; Muscle Cramp; Myalgia; Neuralgia; Osteoarthritis; Pain; Sprains and Strains; Tendinopathy
CAPSAICIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
S07O44R1ZM
Molecule Type:
Small molecule
Molecular Formula:
C18H27NO3
Molecular Weight:
305.42
AlogP:
3.79
PSA:
58.56
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LUMEFANTRINE
(2009)
Small molecule
Ferriprotoporphyrin IX inhibitor
Unknown
Approved
Malaria
LUMEFANTRINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
F38R0JR742
Molecule Type:
Small molecule
Molecular Formula:
C30H32Cl3NO
Molecular Weight:
528.95
AlogP:
9.15
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
10.0
Source:
DRONEDARONE HYDROCHLORIDE
(2009)
Small molecule
Inward rectifier potassium channel 2 blocker
ORAL
Approved
Atrial Fibrillation
DRONEDARONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
FA36DV299Q
Molecule Type:
Small molecule
Molecular Formula:
C31H45ClN2O5S
Molecular Weight:
593.23
AlogP:
7.05
PSA:
88.85
HBD:
1.0
HBA:
#RotB:
18.0
Source:
PRASUGREL HYDROCHLORIDE
(2009)
Small molecule
Purinergic receptor P2Y12 antagonist
ORAL
Approved
Acute Coronary Syndrome; Hemorrhage; Myocardial Infarction
PRASUGREL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
G89JQ59I13
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClFNO3S
Molecular Weight:
409.91
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PAZOPANIB
(2009)
Small molecule
Unknown
Unknown
Approved
Neoplasms
PAZOPANIB
×
Maximum Phase:
4
First Approval:
2009
UNII:
7RN5DR86CK
Molecule Type:
Small molecule
Molecular Formula:
C21H23N7O2S
Molecular Weight:
437.53
AlogP:
3.14
PSA:
119.03
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VIGABATRIN
(2009)
Small molecule
Gamma-amino-N-butyrate transaminase inhibitor
ORAL
Approved
Epilepsy; Epilepsy, Complex Partial; Spasms, Infantile
VIGABATRIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
GR120KRT6K
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO2
Molecular Weight:
129.16
AlogP:
0.36
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BEPOTASTINE
(2009)
Small molecule
Unknown
Unknown
Approved
Unknown
BEPOTASTINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
HYD2U48IAS
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
4.17
PSA:
62.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BESIFLOXACIN
(2009)
Small molecule
Unknown
Unknown
Approved
Eye Infections
BESIFLOXACIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
BFE2NBZ7NX
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClFN3O3
Molecular Weight:
393.85
AlogP:
3.14
PSA:
88.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SAXAGLIPTIN
(2009)
Small molecule
Unknown
ORAL
Approved
Diabetes Mellitus
SAXAGLIPTIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
9GB927LAJW
Molecule Type:
Small molecule
Molecular Formula:
C18H25N3O2
Molecular Weight:
315.42
AlogP:
1.16
PSA:
90.35
HBD:
2.0
HBA:
#RotB:
2.0
Source:
1
2
…
58
59
60
61
62
63
64
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA